Company Overview of Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. engages in discovering and developing small molecule drugs that restore protein function to treat neurodegenerative, metabolic, genetic, and inflammatory disorders. Its products include therapies or Proteostasis regulators to treat various genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as Alzheimer's disease, emphysema, Huntington's disease, and type II diabetes. The company develops its small molecule therapeutics to control the body's protein homeostasis or Proteostasis Network, which is cellular machinery for protein folding, trafficking, and clearance to maintain the body's balance of proteins. Proteostasi...
200 Technology Square
Cambridge, MA 02139
Founded in 2007
Key Executives for Proteostasis Therapeutics, Inc.
Head of External Innovation
Head of Translational Biology
Compensation as of Fiscal Year 2014.
Proteostasis Therapeutics, Inc. Key Developments
Proteostasis Therapeutics, Inc. Appoints Meenu Chhabra as President and Chief Executive Officer
Jun 30 14
Proteostasis Therapeutics, Inc. announced the appointment of Meenu Chhabra as President and Chief Executive Officer. Ms. Chhabra, who will also serve on the Company's Board of Directors, has extensive managerial experience in the biopharmaceutical industry with a strong track record of corporate execution. Her initial focus will be driving the development of the Company's cystic fibrosis franchise while leveraging its proteostasis platform to identify pipeline appropriate assets addressing orphan and neurodegenerative disease indications. Prior to joining Proteostasis, Ms. Chhabra served as the President and Chief Executive Officer since August 2007 at Allozyne, Inc.
Proteostasis Therapeutics, Inc. Presents at 2014 Wells Fargo Healthcare Conference, Jun-17-2014 through Jun-18-2014
Jun 10 14
Proteostasis Therapeutics, Inc. Presents at 2014 Wells Fargo Healthcare Conference, Jun-17-2014 through Jun-18-2014. Venue: InterContinental Hotel Boston, 510 Atlantic Avenu, Boston, MA 02210, United States. Presentation Date(s): Jun-18-2014.
Proteostasis Therapeutics, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 10:20 AM
Mar 19 14
Proteostasis Therapeutics, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 10:20 AM. Venue: The Westin Grand Central Hotel, New York, New York, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 31, 2014
December 9, 2013